Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q2 EPS by 4c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
• Lodestar Metals signs $75,000 investor relations deal with NIA